BACKGROUND: Exercise is safe and beneficial for people with multiple sclerosis (MS). Functional electrical stimulation (FES) cycling offers people with significant weakness and mobility challenges an option for exercise. We sought to evaluate the safety of FES cycling and its potential to improve fatigue, pain, spasticity, and quality of life in people with moderate-to-severe MS. METHODS: Sixteen participants with MS who were nonambulatory cycled for 30 minutes two to three times a week for 1 month. Outcomes assessed included MS Quality of Life Inventory (MSQLI) subscales, Modified Ashworth Scale (MAS), and manual muscle test (MMT). RESULTS: Fourteen participants (six women and eight men) with MS completed the training. All were able to maintain or increase their cycle time; half increased the resistance while cycling. Participants demonstrated a significant decrease in the Physical (P = .02) and Psychosocial (P < .01) subscales of the Modified Fatigue Impact Scale. There was no significant change in the other MSQLI subscale scores. There was no change in MAS and MMT scores. Type of MS and the use of antispasticity medications, disease-modifying therapies, or dalfampridine did not seem to influence response to training. There were no adverse events. CONCLUSIONS: Functional electrical stimulation cycling may be a viable and effective exercise option for people with moderate-to-severe MS. Further study is required to examine the parameters of FES cycling that are most effective for people with different MS symptoms and to fully explore the potential benefits of optimizing function and improving health in people with MS.
BACKGROUND: Exercise is safe and beneficial for people with multiple sclerosis (MS). Functional electrical stimulation (FES) cycling offers people with significant weakness and mobility challenges an option for exercise. We sought to evaluate the safety of FES cycling and its potential to improve fatigue, pain, spasticity, and quality of life in people with moderate-to-severe MS. METHODS: Sixteen participants with MS who were nonambulatory cycled for 30 minutes two to three times a week for 1 month. Outcomes assessed included MS Quality of Life Inventory (MSQLI) subscales, Modified Ashworth Scale (MAS), and manual muscle test (MMT). RESULTS: Fourteen participants (six women and eight men) with MS completed the training. All were able to maintain or increase their cycle time; half increased the resistance while cycling. Participants demonstrated a significant decrease in the Physical (P = .02) and Psychosocial (P < .01) subscales of the Modified Fatigue Impact Scale. There was no significant change in the other MSQLI subscale scores. There was no change in MAS and MMT scores. Type of MS and the use of antispasticity medications, disease-modifying therapies, or dalfampridine did not seem to influence response to training. There were no adverse events. CONCLUSIONS: Functional electrical stimulation cycling may be a viable and effective exercise option for people with moderate-to-severe MS. Further study is required to examine the parameters of FES cycling that are most effective for people with different MS symptoms and to fully explore the potential benefits of optimizing function and improving health in people with MS.
Authors: Camilla Sköld; Lars Lönn; Karin Harms-Ringdahl; Claes Hultling; Richard Levi; Mark Nash; Ake Seiger Journal: J Rehabil Med Date: 2002-01 Impact factor: 2.912
Authors: John N Ratchford; Wendy Shore; Edward R Hammond; J Gregory Rose; Robert Rifkin; Pingting Nie; Kevin Tan; Megan E Quigg; Barbara J de Lateur; Douglas A Kerr Journal: NeuroRehabilitation Date: 2010 Impact factor: 2.138
Authors: Johann Szecsi; Cornelia Schlick; Martin Schiller; Walter Pöllmann; Nikolaus Koenig; Andreas Straube Journal: J Rehabil Med Date: 2009-07 Impact factor: 2.912
Authors: Rob McCarney; James Warner; Steve Iliffe; Robbert van Haselen; Mark Griffin; Peter Fisher Journal: BMC Med Res Methodol Date: 2007-07-03 Impact factor: 4.615
Authors: Rosalind Kalb; Theodore R Brown; Susan Coote; Kathleen Costello; Ulrik Dalgas; Eric Garmon; Barbara Giesser; June Halper; Herb Karpatkin; Jennifer Keller; Alexander V Ng; Lara A Pilutti; Amanda Rohrig; Paul Van Asch; Kathleen Zackowski; Robert W Motl Journal: Mult Scler Date: 2020-04-23 Impact factor: 6.312
Authors: Thomas Edwards; Anne Sophie Michelsen; Afolasade O Fakolade; Ulrik Dalgas; Lara A Pilutti Journal: J Sport Health Sci Date: 2021-07-27 Impact factor: 13.077